Ultragenyx Pharmaceutical GAAP EPS of -$1.40 Beats by $0.08, Revenue of $139.45M Beats by $4.2M

Seeking Alpha05:12

Express News | Ultragenyx Pharmaceutical Inc: Reaffirmed 2024 Expected Total Revenue Guidance of $530 Mln to $550 Mln

Breakings05:02

Press Release: Ultragenyx Reports Third Quarter 2024 Financial Results and Corporate Update

Dow Jones05:01

Ultragenyx Pharma 3Q Rev $139.5M >RARE

Dow Jones05:01

Express News | Ultragenyx Q3 Net Income USD -134 Million

Breakings05:01

Express News | Ultragenyx Q3 Operating Expenses USD 271 Million

Breakings05:01